1-溴-2,5-二氯-3-氟苯 | 202865-57-4

• 物质功能分类: 有机原料 - 烃类化合物及其衍生物 - 芳香烃
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-溴-2,5-二氯-3-氟苯
• 中文别名: 2,5-二氯-3-氟溴苯；3-溴-2,5-二氯氟苯
• 英文名称: 1-bromo-2,5-dichloro-3-fluorobenzene
• CAS: 202865-57-4
• 化学式: C₆H₂BrCl₂F
• 分子量: 243.89
• InChiKey: CAYJMDVKWMVOLG-UHFFFAOYSA-N

物化性质

• 沸点：
  232℃
• 密度：
  1.823
• 闪点：
  94℃
• 稳定性/保质期：
  避氧化物

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• 海关编码：
  2903999090
• 安全说明：
  S24/25
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
1-Bromo-2,5-dichloro-3-fluorobenzene
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
1-Bromo-2,5-dichloro-3-fluorobenzene
Ingredient name:
CAS number: 202865-57-4

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H2BrCl2F
Molecular weight: 243.9

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-溴-2,5-二氯-3-氟苯 在 四(三苯基膦)钯 N-溴代丁二酰亚胺(NBS) 、 sodium azide 、 18-冠醚-6 、 偶氮二异丁腈 、 potassium tert-butylate 、 水 、 三苯基膦 作用下， 以 四氢呋喃 、 四氯化碳 、 二甲基亚砜 为溶剂， 反应 161.25h， 生成 3-{[3-(aminomethyl)-6-chloro-2-fluorophenyl]oxy}-2,5-dichlorobenzonitrile
  参考文献：
  名称：

  WO2008/154271

  摘要：

  公开号：
• 作为产物：
  描述：

  2-溴-4-氯-6-氟苯胺 在 硫酸 、 亚硝基硫酸 、 盐酸 、 copper(l) chloride 作用下， 以 水 为溶剂， 生成 1-溴-2,5-二氯-3-氟苯
  参考文献：
  名称：

  一种1-溴-2,5-二氯-3-氟苯的制备方法

  摘要：

  本发明公开的一种1‑溴‑2,5‑二氯‑3‑氟苯的制备方法，包括以下步骤：步骤一：溴化反应；步骤二：氯代反应。本发明属于精细化工中间体制备技术领域，本发明提供一种1‑溴‑2,5‑二氯‑3‑氟苯的制备方法，将化合物2‑氟‑4‑氯苯胺经过溴化、氯代合成了1‑溴‑2,5‑二氯‑3‑氟苯，丰富了抗癌、抗病毒药物关键中间体合成方法，同时化合物1‑溴‑2,5‑二氯‑3‑氟苯的制备方法，具有原料易得、收率高、操作简单的优点，适宜工业化生产的目的，通过此方法制备的一种1‑溴‑2,5‑二氯‑3‑氟苯可以达到大规模工业化生产、副反应少、收率高、产品纯度高的技术效果。

  公开号：

  CN115611700A

文献信息

• [EN] SYNTHESIS OF NOVEL INTERMEDIATES FOR SUBSTITUTED 3,4-DIHYDROISOQUINOLINONES<br/>[FR] SYNTHÈSE DE NOUVEAUX INTERMÉDIAIRES POUR 3,4-DIHYDROISOQUINOLINONES SUBSTITUÉES
  申请人：PFIZER

  公开号：WO2022018594A1

  公开（公告）日：2022-01-27

  This invention relates novel intermediates used for the synthesis of substituted 3,4-dihydroisoquinolinone compounds which are EZH2 inhibitors and the synthesis of said intermediates.

  这项发明涉及用于合成取代3,4-二氢异喹啉酮化合物的新型中间体，这些化合物是EZH2抑制剂，以及所述中间体的合成。
• [EN] ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR<br/>[FR] COMPOSÉS D'ISOINDOLINONE ET D'INDAZOLE POUR LA DÉGRADATION DE L'EGFR
  申请人：C4 THERAPEUTICS INC

  公开号：WO2021127561A1

  公开（公告）日：2021-06-24

  The invention provides compounds that degrade the epidermal growth factor receptor (EGFR) including mutant forms via the ubiquitination of the EGFR protein and subsequent proteasomal degradation. The compounds are useful for the treatment of various cancers.

  这项发明提供了通过泛素化表皮生长因子受体（EGFR）蛋白并随后的蛋白酶体降解来降解EGFR，包括突变形式的化合物。这些化合物对于治疗各种癌症是有用的。
• Non-nucleoside reverse transcriptase inhibitors
  申请人：Dunn Patrick James

  公开号：US20050239881A1

  公开（公告）日：2005-10-27

  The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula I where Ar, R 1 -R 5 , R 7a , R 7b , R 7c , R 8 -R 10 , X 1 , X 2 m, n, o and p are as defined herein.

  本发明提供了用于治疗或预防HIV感染，治疗艾滋病或ARC的化合物，包括根据以下公式I给予化合物，其中Ar，R1-R5，R7a，R7b，R7c，R8-R10，X1，X2m，n，o和p如本文所定义。
• Methods for treating retroviral infections
  申请人：Dunn Patrick James

  公开号：US20050239880A1

  公开（公告）日：2005-10-27

  The present invention provides compounds for treating or preventing an HIV infection, or treating AIDS or ARC comprising administering a compound according to formula I where Ar, R 1 -R 5 , R 11c and X 1 are as defined herein.

  本发明提供了用于治疗或预防HIV感染，治疗艾滋病或ARC的化合物，包括根据本文所定义的公式I给药的化合物，其中Ar、R1-R5、R11c和X1如本文所定义。
• Pyrazine Derivatives
  申请人：Denton Martin Stephen

  公开号：US20070105872A1

  公开（公告）日：2007-05-10

  The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.

  本发明涉及公式化合物及其药用可接受盐和溶剂，用于制备该化合物的过程，用于制备的中间体，含有这种化合物的组合物以及用于治疗疼痛的这种化合物的用途。